Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
in full; Detailed Quote for LIG Assets Inc. (LIGA)
$ 0.0075 0.0002 (+2.74%) Volume: 160 k 10:40 AM EDT May 6, 2013
LIG Assets, Inc. Updates Progress of LIG Entertainment
DALLAS, May 6, 2013 /PRNewswire/ -- LIG Assets, Inc. (OTCPK: LIGA), a Company focused on residential and commercial real estate, announces that the following update on its division, LIG Entertainment Management, Inc. Based on initial interest from several parties in its "two film" movie deal, parent Company LIG Assets, Inc. estimates that it will enjoy profits of over $1 million, and the number is likely to surpass the total market capitalization of LIG Assets stock based on its most recent closing price.
On January 10, 2013, LIG Assets announced it had formed a new subsidiary to assist with the finance of low budget movies with the assistance of State Grants established to encourage filming it its home state of Texas. Even though this division is not the focus of LIG Assets and will not be in the future, it appears that it is now positioned to generate a strong return from the production of two feature length films.
LIG Entertainment Management, Inc. in association with Legacy Film Studios of Texas and Back in the Saddle Productions, LLC (BITS) has wrapped principal photography on their independent feature "HOA The Movie" in the greater San Antonio, Texas area. This is the first of a "two film" deal. Their second feature, "The Water's Edge", with only a few more days of filming, is also already into post-production. All post-production services are being handled by Bauhaus Media Group of San Antonio. Edwin Licona of Emerge Filmworks has signed on to consult on distribution and marketing.
These new films feature Daniel Baldwin (Vampires, Homicide, Hawaii Five O), Jesse Borrego (Blood in Blood Out, Con-Air, Colombiana), Mayra Leal (Machete, Southland, Asylum), and European fitness girl Kristen Wojciechowski making her feature film debut. Both pictures are scheduled to be available for release by this summer (2013).
"HOA The Movie" is a film in the comedic vain of Caddy Shack and Animal House. Written by newcomer, John Quest, the story follows Lucky Bets and his fellow "new" HOA board members in their madcap attempts to not take the blame for money missing from the HOA bank account. Having been set up by the "old" board to take the hit for their wrongdoing, Lucky and his band of misfits must come up with a con of their own to get even and stay out of jail. John Quest is also credited as co-director for the film.
http://www.dailymotion.com/video/xwzfgx_hoa-the-movie_news#.UYeoNLGDdQk.email
"The Water's Edge" is a project previously produced, that LIG Entertainment is resurrecting, restructuring and redirecting to bring it back to life and into the marketplace. This film is believed to have significant merit, but for one reason or another was unfinished or an unfulfilled project.
"The Water's Edge" is based on an original award winning script about a family beat down by a series of traumatic events. The dark tone of the story and some of the technical limitations due to budgetary restraints ultimately bogged the project down.
About LIG Assets, Inc.
LIG Assets, Inc., (LIGA) based in Dallas, TX, is a Company focused on residential and commercial real estate. Through our Strategic Alliance with Texas Real Estate Hedge Fund, MMR Realty Advisors, and InterContinental Real Estate Partners, LIG Assets will expand its focus on multifamily, retail, hotel, and office properties with valuations between $3 and $100 million. LIG Assets also owns LIG Entertainment Management, Inc., a division formed to help finance low budget movies filmed in the State of Texas.
Forward-Looking Statements
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings and disclosures at www.OTCmarkets.com.
Contact:
LIG Assets, Inc.
(214) 760-1000
www.ligassetsinc.net
SOURCE LIG Assets, Inc.
Source: PR Newswire (May 6, 2013 - 9:29 AM EDT)
News by QuoteMedia
SLTD nice move off the bottom last week. Continuing this morning. +12% to .0235. Good vol too.
in full; Mon, May 06, 2013
8:35 AM MMRGlobal Patent Valuation Increases From Issuance of Japanese Patent - Marketwired
re;
MMRGlobal Patent Valuation Increases From Issuance of Japanese Patent
http://media.marketwire.com/attachments/201105/71936_MMRGlobalnew2010mw.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1013972&ProfileId=051205&sourceType=1
LOS ANGELES, CA -- (Marketwired) -- 05/06/13 -- MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs) MyEsafeDepositBox storage solutions and MMRPro document management and imaging systems for healthcare professionals, is featured in an updated valuation report following the issuance by the Japan Patent Office of Patent No. 5191895 entitled a "Method and System for Providing Online Medical Records." The Japanese patent, issued on February 8, 2013, increases the valuation by the Michael Bass Research Group by $200 million, from an initial report of $600 million to $1.1 billion, to $800 million to $1.3 billion.
The report can be seen at http://michaelbass.com/PDF/Patent_Valuation.pdf. The Japanese patent includes 40 claims relating to accessing health records through a Web site, collecting health records directly from healthcare providers, and managing the records such as by organizing the documents, applying additional password protection, and electronically sending the health records to healthcare providers.
The patent is specifically relevant to the market at this time following the launch of the country's "My Hospital Everywhere" Japan Personal Health Record service concept. Additional patent applications are also pending in Japan.
The "My Hospital Everywhere" program is designed to help enable individuals in Japan to receive their own medical and health-related information from medical institutions and to maintain and manage it electronically, which is a significant part of MMR's patented technologies.
The implementation of Electronic Medical Records in Japan is a high priority as a result of findings from the aftermath of the March 11, 2011 earthquake and tsunami. The medical system in Japan was overwhelmed with thousands of people in hospitals and doctors' offices with no medical records. As a result, thousands unnecessarily lost their lives, and the cost of care without having information about the patient was significantly increased, making deployment of "My Hospital Everywhere" a national priority.
The value of the Company's patents in Japan is underscored by an interview with Dr. Makoto Aoki in The National Bureau of Asian Research on June 2, 2011. Dr. Aoki, Scientific Executive at Sakura Seiki Co. Ltd., a Japanese company that specializes in the design and manufacturing of medical and laboratory equipment, and
a Member of the American College of Physicians, said, "Physicians have had a hard time identifying patients' medications since patients often remember their medications only by their shape or color. Most of the hospitals that patients had attended also lost their medical records as a result of the earthquake or tsunami." MMR's PHR systems include the ability to track and manage a patient's medication data base.
MMR has seven issued U.S. patents as well as additional applications and continuation applications with nearly 400 claims relating to Personal Health Records transmitted via an Internet portal under the heading of "Method and System for Providing Online Medical Records" and "Method and System for Providing Online Records." MMR's patent portfolio also includes numerous other issued patents and pending applications in countries of commercial interest around the world which, in addition to Japan, include Australia, Singapore, New Zealand, Mexico, Canada, Hong Kong, South Korea, Israel, and European nations.
The report by the Michael Bass Research Group also includes the earlier report presenting a comprehensive overview of the U.S. Personal Health Records market, with particular emphasis on MMRGlobal's MyMedicalRecords Health Information Technology Global Patent portfolio. This report includes schedules of the Company's domestic and international MMR patent portfolios, a valuation analysis and summary of conclusions.
The Company's patents also contain claims directed to Web-based services that provide access to and collect health records from service providers, including, but not limited to, retail pharmacies and laboratory systems as well as hospitals, physicians and other healthcare professionals, using email, facsimile, file upload and voice. Certain claims in newly allowed applications also relate to collecting insurance information, appointment and medication reminders and other features that are already included in MMR's MyMedicalRecords.com PHR.
About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma.
To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.
About The Michael Bass Group:
The Michael Bass Group (MBG) (http://michaelbass.com) is an investment banking and strategic advisory services firm focused on healthcare information technology, healthcare IT services, and mobility providers as well as medical devices. MBG tracks and conducts research on over 400 emerging growth companies in the HIT sector. The Michael Bass Research Group also looks at economic, market, industry and company data relevant to the healthcare sector.
Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, whether or not such statement relates directly to the Michael Bass Research Group valuation reports, and including, without limitation, intellectual property licenses, property enforcement actions, infringement claims or litigation, and future performance, management's expectations, beliefs, intentions, estimates or projections,
constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue,"
or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets,
including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry both in the U.S. and internationally; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel;
other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission, including disclosures about the Company's relationship with the Michael Bass Group since 2009. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
Add to Digg Bookmark with del.icio.us Add to Newsvine
CONTACT:
Michael Selsman
Public Communications Co.
ms@publiccommunications.biz
(310) 922-7033
Source: Marketwired (May 6, 2013 - 8:35 AM EDT)
News by QuoteMedia
BMSN Bio-Matrix Scientific Group's Regen BioPharma Acquires Cancer Vaccine Technology With Initial Focus on Breast Cancer
Broad-Based Patent Assigned to Regen Covers Gene Silencing Non-Toxic Cancer Immunotherapy
SAN DIEGO, CA, May 06, 2013 (Marketwired via COMTEX) -- Regen BioPharma, wholly owned subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN), announced today it has purchased patent #8,389,708 from Professor Wei-Ping Min of the University of Western Ontario, London, Canada. This patent covers a novel means of stimulating the immune system against cancer through blockade of a cancer specific molecular pathway (gene silencing). Preclinical studies demonstrating effective stimulation of anticancer immunity and molecular mechanisms mediating therapeutic effects of the technology have been reported in the Journal of Immunology(1).
"The blockbuster potential of cancer immune therapies is illustrated by the $1.66 Billion sales of Herceptin(2), a monoclonal antibody used to treat breast cancer, in 2011," said David Koos, Chairman and CEO of Bio-Matrix Scientific Group Inc. and its subsidiary, Regen BioPharma Inc. "This newly acquired technology has passed the preclinical stages of testing and we are eager to continue development through the FDA IND process."
The acquired technology covers the use of RNA Interference to specifically inhibit the enzyme indolamine 2,3 deoxygenase (IDO). Tumors are known to escape the immune system by specifically activating this enzyme. In the patent and previous publication, Dr. Min and his team demonstrated that by blocking function of IDO, tumors would enter remission.
"My laboratory is looking forward to working with Bio-Matrix Scientific's Regen BioPharma towards advancing our new method of treating cancer from mice to people," stated Dr. Wei-Ping Min, Professor at the University of Western Ontario. "Having previously published(3) with Dr. Koos on our RNA interference technique, I am eager to now expand our collaboration into the area of oncology."
The cancer vaccine market is expected to grow from a 2010 value of US$12.8 billion, to US$17.4 billion by 2018. Approximately 1.5 million Americans are being diagnosed with cancer annually, and the annual overall cost of the disease is estimated to be $230 billion(4).
About Bio-Matrix Scientific Group Inc. and Regen BioPharma, Inc.:
Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) through its wholly owned subsidiary, Regen BioPharma, Inc., is a biotechnology company focused on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/II clinical trials. To follow our development, visit us at www.regenbiopharma.com.
10Q- out!!>>>>>>>>>BISU<<<<<<<++Athletes..news_coming..+Diab++mariju
<<< $GNCP >>> GNCC Capital, Inc. (GNCP:OB) is focused on its three gold and three silver exploration projects located in Arizona, USA.
$GNCP Website: http://www.gncc-capital.com/
$GNCP News: http://finance.yahoo.com/q/h?s=GNCP+Headlines
$GNCP Live Chart: http://stockcharts.com/c-sc/sc?s=GNCP&p=D&b=9&g=0&i=p69412508847&r=1361457330369
$GNCP DD/Profile: http://www.wallstreetsurfers.com/gncp/
/^\$FBCD/^\ Background
$FBCD Website: http://fbcholdinginc.com/
$FBCD News: http://finance.yahoo.com/q/h?s=FBCD+Headlines
$FBCD Live Chart: http://stockcharts.com/c-sc/sc?s=FBCD&p=D&b=14&g=0&i=p11991308655&r=1367801356411
$FBCD DD/Profile: http://www.sizzlingstockpicks.com/featured-sizzler-fbcd/
/^\$GNCP/^\ Our Mission >>
http://www.gncc-capital.com/Mission.html
We create value for our shareholders, our employees and our business and social partners through safely and responsibly exploring, mining and marketing our products. Our primary focus is gold and we will pursue value-creating opportunities in other minerals where we can leverage our existing assets, skills and experience to enhance the delivery of value.
$GNCP Website: http://www.gncc-capital.com/
$GNCP News: http://finance.yahoo.com/q/h?s=GNCP+Headlines
$GNCP Live Chart: http://stockcharts.com/c-sc/sc?s=GNCP&p=D&b=9&g=0&i=p69412508847&r=1361457330369
$GNCP DD/Profile: http://www.wallstreetsurfers.com/gncp/
+++ $GNCP +++ Safety is our first value.
We place people first and correspondingly put the highest priority on safe and healthy practices and systems of work. We are responsible for seeking out new and innovative ways to ensure that our workplaces are free of occupational injury and illness. We live each day for each other and use our collective commitment, talents, resources and systems to deliver on our most important commitment ... to care.
$GNCP Website: http://www.gncc-capital.com/
$GNCP News: http://finance.yahoo.com/q/h?s=GNCP+Headlines
$GNCP Live Chart: http://stockcharts.com/c-sc/sc?s=GNCP&p=D&b=9&g=0&i=p69412508847&r=1361457330369
$GNCP DD/Profile: http://www.wallstreetsurfers.com/gncp/
GO VNDB!! Thanks for the chart!
Bisu chart mick,Move with news this week!!
$FBCD Consumer Products!!!
The Company has been in discussions with a Company that possesses a technology that can print very simple to moderately complex electronic circuitry on to nearly any surface including textiles, plastics, metal and paper. Such technology has myriad applications and FBC is discussing lighting applications that can be powered by circuitry that can be painted or printed on to a surface without wires or any “hard” electronic components.
We are currently at various stages of involvement with each of these companies and we are continually on the lookout for new businesses that we can make a part of our Company and we expect to be able to provide some further information on one or more in the days and weeks to come.
We realize that over the last six years FBC Holding has presented several business plans and morphed from a mining company to a toy company to an action sports company as well as a few more in between. FBC is, first and foremost, a Holding Company. We are going to seek out businesses with solid plans, in a growing industry with specific characteristics. We will not seek to rush into any transaction but rather will perform thorough due diligence and only consider transactions that we believe can be immediately accretive to earnings.
FBCD FBC Holding Inc. Retail - Wholesale Distributors
FORUM;http://investorshub.advfn.com/First-Colombia-Gold-Corp-FCGD-18978/
Natural Resources
FBC Holding began as a uranium mining company. The Company is currently reviewing several opportunities in natural resource mining. The companies that are being considered are all production-stage companies that are producing monthly revenues and would be immediately accretive to earnings.
$FBCD Company Profile
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87586436&txt2find=fbcd
EXCERPT;
Company Overview
Website - http://fbcholdinginc.com
Background
FBC Holding was formed back in 2006 and has gone through several iterations and business plans since then. Most recently, we planned to become involved in the actions sports business and our former management represented to have negotiated a deal with a company which also represented that it owned certain licensing rights to a unique type of skateboard called the Flowboard.
Security Details
Share Structure
Market Value1 $333,786 a/o May 03, 2013
Shares Outstanding 38,366,153 a/o Mar 18, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders
Shareholders of Record 75 a/o Nov 21, 2012
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87586218&txt2find=fbcd
http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=fbcd
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87587201&txt2find=fbcd
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87586666&txt2find=fbcd
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87586486&txt2find=fbcd
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87317148&txt2find=fbcd
[-chart]stockcharts.com/c-sc/sc?s=fbcd&p=D&b=4&g=0&i=p78460050143&r=1360892533388[/chart]
update/cfgx re;
CEO Update: Uplist Progress
Friday, April 26, 2013 09:01 PM
.
I've had a few investors reach out inquiring about the Company's progress with our effort to uplist to the OTCQB Tier.
I just want to let you all know that we are still working through the final pieces of the audit so we can begin the SEC paperwork and that we are very, very close.
If any of you have more specific questions, fire them off to http://www.ir@capfiglobal.com and I'll try to get them answered here in the blog.
Thanks for your continued support!
Paul Edward Norat, CEO
Capital Financial Global, Inc.
@CFGX
Facebook
http://www.capfiglobal.com/investor-center/ceo-blog/98-ceo-update-uplist-progress
leverage ones bring good profits.
Let's ROCK VNDB!
$VRNI The Cannabis Connection's locations are expected to be located in and around affluent urban neighborhoods and business centers, as well as in affluent suburban areas. These locations would be intended to provide ease of access and convenience to The Connection's target client base, affluent baby boomers who require the use of medicinal marijuana on a regular basis. The company's management is convinced that convenient access to The Connection's dispensaries is a primary requirement to attracting its target client base.
excerpt; Astaxanthin: The defining natural miracle of the 21st century?
fact that ObamaCare is going to leave us 140,000 doctors short in just a few years.
Millions of people won't be able to get anywhere near a doctor's office, so they'll have no choice but to turn to convenience-store medicine from places like Walgreens/ wag, which is right now staffed with low-cost nurse practitioners and physician assistants instead of real doctors.
Walgreens investors, who are now perfectly positioned for the ObamaCare future.
Breast screenings unsafe at any price
Japan claims that cutting the copay out of the mammogram equation can almost double the rate of screenings practically overnight.
CYIO presented to the U.S. Army and to large integrators for possible licensing.
CYIOS built America's Army Online, the first Army Knowledge Management solution that was developed to become the core for Army Knowledge Online (AKO), the U.S. Army's main intranet serving over 1.8 million registered users.
CYIOS continued innovating in knowledge management with the development of CYIPRO, a virtual office solution for collaboration, accountability, knowledge management and teleworking that features document management and versioning, project and task management, e-mail encryption, full-text search, timesheets, meetings, and reports.
VRNI Virogen's New Business Unit, "The Cannabis Connection," to Focus on High-End Medicinal Marijuana Dispensary Niche within $15-20 Billion Legal Marijuana Market PR Newswire03:50pm EDT
2's and 3's would have been just fine
yes on that but very few traded as i read.
would have liked the .0001's on suti looks like a easy 100% from here
suti really looks good for a move up irce holding
both look good in mid-trips. irce suti
will keep on watch
me too be nice to see new high of 52 weeks
been buying irce need suti man i cant believe i keep forgetting
just needs reinstated. ario
i think kelly mine deal turns into biggy.
re;
South American Gold (SAGD)
0.0016-0.0001 (-5.88%) 2:50P EDT (OTHER OTC)
Stock Price Quote as of Friday, May 3rd, 2013
High 0.0018 Low 0.0014
0.1000 52Wk High
(-98.40%) Since 06/08/12 0.0010 52Wk Low
(+60.00%) Since 04/01/13
Open 0.0018 Prev Close 0.0017
Volume 12,322,816 Avg Volume 16,269,851 EPS 0.00 Div & Yield N/A
P/E Ratio 0.0000 Market Cap N/A
Weighted Alpha -83.35 Standard Dev -0.25
buy on dips? irce suti
re;
Why do i keep forgeting suti Sutimco International Inc (SUTI)
0.0006+0.0001 (+20.00%) 3:59P EDT (OTHER OTC)
Stock Price Quote as of Friday, May 3rd, 2013
High 0.0006 Low 0.0005
0.2300 52Wk High (-99.74%) Since 05/18/12 0.0001 52Wk Low
(+500.00%) Since 04/29/13
Open 0.0006 Prev Close 0.0005
Volume 1,360,000 Avg Volume 12,274,024
Lig Assets Inc. (LIGA)
0.0073-0.0027 (-27.00%) 3:59P EDT (OTHER OTC) - After Hours: 0.0090+0.0017 (+23.29%) 4:03P EDT] Stock Price Quote as of Friday, May 3rd, 2013
High 0.0100 Low 0.0073
0.0800 52Wk High
(-90.88%) Since 05/07/12 0.0051 52Wk Low
(+43.14%) Since 02/28/13
Open 0.0091 Prev Close 0.0100
Volume 2,885,600 Avg Volume 4,705,690
EPS 0.00 Div & Yield N/A
P/E Ratio 0.0000 Market Cap N/A
Weighted Alpha -94.71 Standard Dev -1.45
40.54% 14-Day Rel Strength 0.00% 14-Day Stochastic
Why do i keep forgeting suti Sutimco International Inc (SUTI)
0.0006+0.0001 (+20.00%) 3:59P EDT (OTHER OTC)
Stock Price Quote as of Friday, May 3rd, 2013
High 0.0006 Low 0.0005
0.2300 52Wk High (-99.74%) Since 05/18/12 0.0001 52Wk Low
(+500.00%) Since 04/29/13
Open 0.0006 Prev Close 0.0005
Volume 1,360,000 Avg Volume 12,274,024
South American Gold (SAGD)
0.0016-0.0001 (-5.88%) 2:50P EDT (OTHER OTC)
Stock Price Quote as of Friday, May 3rd, 2013
High 0.0018 Low 0.0014
0.1000 52Wk High
(-98.40%) Since 06/08/12 0.0010 52Wk Low
(+60.00%) Since 04/01/13
Open 0.0018 Prev Close 0.0017
Volume 12,322,816 Avg Volume 16,269,851 EPS 0.00 Div & Yield N/A
P/E Ratio 0.0000 Market Cap N/A
Weighted Alpha -83.35 Standard Dev -0.25
Solar3D Inc (SLTD)
0.0210+0.0075 (+55.56%) 3:54P EDT (OTHER OTC) - [After Hours: 0.0215+0.0005 (+2.38%) 4:00P EDT]
Stock Price Quote as of Friday, May 3rd, 2013
High 0.0300 Low 0.0170
0.0600 52Wk High (-65.00%) Since 09/10/12 0.0085 52Wk Low
(+147.06%) Since 04/26/13
Open 0.0280 Prev Close 0.0135
Volume 2,436,648 Avg Volume 912,797
EPS 0.00 Div & Yield N/A
P/E Ratio 0.0000 Market Cap N/A
Weighted Alpha -80.93 Standard Dev +2.84
65.44% 14-Day Rel Strength 58.14% 14-Day Stochastic
ario may wake up?
Followers
|
12
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1322
|
Created
|
04/12/12
|
Type
|
Free
|
Moderator ManicTrader | |||
Assistants mick Penny Roger$ |
Posts Today
|
0
|
Posts (Total)
|
1322
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |